$IQV

BOUSBIB ARI sold $26.1M of IQV

BOUSBIB ARI (See Remarks) sold 106,279 shares of IQVIA HOLDINGS INC. (IQV) at an average of $245.51 ($244.78–$247.10, $26.09M total) across 4 trades on 2026-07-29.

Original reporting
SEC EDGAR · BOUSBIB ARI
Published Jul 31, 2026, 9:02 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 9:06 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$IQV
Neutral
low confidence
Mentioned
$IQV
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IQVNeutralLow
01

Why it matters

The newest fact is the disclosed sale size ($26.09M) and the trade price range ($244.78 to $247.10) by an officer/director on 2026-07-29.

02

Market read

Traders may monitor for follow-on insider activity or interpret the sale as mild negative sentiment, but there is no new operating or financial guidance in the filing.

03

What to watch

The text does not state whether the sale was part of a broader program, tax event, or diversification plan, and it provides no context on prior insider activity.

Relevance 7/10Novelty 5/10Timing: filed 2026-07-31 after trades dated 2026-07-29

Background

This is an SEC Form 4 insider transaction disclosure for IQVIA Holdings Inc.

Company-level read

Ticker impact

$IQVNeutralLow confidence
Context

IQVIA Form 4 shows officer/director BOUSBIB ARI sold $26.1M of IQV shares in open-market transactions at $244.78 to $247.10 on 2026-07-29.

Expected impact

Likely limited, short-lived sentiment impact unless follow-on selling or new fundamentals emerge.

Evidence & confidence

The filing is a routine Form 4 insider sale with no 10b5-1 plan stated and no accompanying company-specific operational update in the text.

Market effects

No sector-wide read-through is provided; this is company-specific insider activity only.

None indicated.

None indicated.

Counterpoint

Insider sales can be planned for liquidity or diversification, so the signal may be overstated without evidence of distress or a 10b5-1 plan.

Key entities

  • IQVIA HOLDINGS INC.

    Subject of the Form 4 insider sale disclosure.

  • BOUSBIB ARI

    Officer and director who sold 106,279 shares across four trades.

Related articles

$IQVMed

5 Insightful Analyst Questions From IQVIA’s Q2 Earnings Call

IQVIA reported Q2 CY2026 results with revenue of $4.37B versus $4.30B estimates and adjusted EPS of $3.15 versus $3.03, with adjusted EBITDA of $994M. Management cited 6% organic growth and strong net new bookings. Full-year revenue guidance was lifted to $17.38B and adjusted EPS to $12.90. Analysts discussed bookings, outsourcing, AI, M&A, and margins.

Med

An IQVIA CEO Sold $26.1 Million as Bookings Hit a Record $3.15 Billion

IQVIA Holdings CEO sold about $26.1 million of stock appreciation rights with a Feb 2027 expiration, while retaining a large share position, according to the filing and article. The company reported Q2 revenue up 8.7% to $4.37B, adjusted EPS up 12.1% to $3.15, and record clinical bookings of $3.15B, raising full-year guidance to $17.475B.

MedAI 8/10

IQVIA Holdings Inc. Q2 2026 Earnings Call Summary

IQVIA reported Q2 2026 results and said organic revenue growth accelerated to 6% YoY, driven by improving market conditions and execution. Management raised full-year 2026 guidance, citing 100 bps higher organic growth and more M&A contribution. It expects flat adjusted EBITDA margins around 23.2% and noted Charles River asset acquisition added 50 bps to M&A growth.

$IQVMedAI 8/10

IQVIA Holdings (IQV) Soars on Revenue Growth Outlook, Strong Q2

IQVIA Holdings (NYSE:IQV) rose after reporting strong Q2 results and raising its full-year revenue growth outlook. Q2 revenue grew 8.7% to $4.37B, while attributable net income fell 3.7% to $256M. FY26 revenue guidance increased to $17.275B-$17.475B, with adjusted EBITDA $4.0B-$4.05B and buybacks of $2.819B authorized.

$IQVMedAI 8/10

IQVIA Holdings Boosts FY26 Outlook; Shares Surge 10.6% - Update

IQVIA Holdings reported Q2 results and raised its FY2026 guidance. The company now expects adjusted earnings of $12.80 to $13.00 per share and revenue of $17.275 billion to $17.475 billion, citing stronger organic growth and updated M&A and FX impacts. Shares were up about 10.6% to $236.04 premarket.